Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 10241
Country/Region: Zambia
Year: 2015
Main Partner: Catholic Relief Services
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $4,187,292 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $400,000
Care: TB/HIV (HVTB) $220,000
Care: Pediatric Care and Support (PDCS) $100,000
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $232,292
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $250,000
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $2,650,000
Treatment: Pediatric Treatment (PDTX) $335,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR_DSD Age/sex: <1 Female 2016 319
CARE_CURR_DSD Age/sex: <1 Male 2016 319
CARE_CURR_DSD Age/sex: 1-4 Female 2016 458
CARE_CURR_DSD Age/sex: 1-4 Male 2016 689
CARE_CURR_DSD Age/sex: 10-14 Female 2016 859
CARE_CURR_DSD Age/sex: 10-14 Male 2016 845
CARE_CURR_DSD Age/sex: 15-19 Female 2016 639
CARE_CURR_DSD Age/sex: 15-19 Male 2016 899
CARE_CURR_DSD Age/sex: 20-24 Female 2016 1,366
CARE_CURR_DSD Age/sex: 20-24 Male 2016 742
CARE_CURR_DSD Age/sex: 25-49 Female 2016 9,197
CARE_CURR_DSD Age/sex: 25-49 Male 2016 4,665
CARE_CURR_DSD Age/sex: 5-9 Female 2016 629
CARE_CURR_DSD Age/sex: 5-9 Male 2016 613
CARE_CURR_DSD Age/sex: 50+ Female 2016 1,753
CARE_CURR_DSD Age/sex: 50+ Male 2016 1,745
CARE_CURR_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 25,737
CARE_CURR_DSD Sum of Age/Sex disaggregates 2016 25,737
CARE_NEW_DSD Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 4,452
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 546
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 617
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 4,469
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 4,957
HTC_TST_DSD By Test Result: Negative 2016 9,752
HTC_TST_DSD By Test Result: Positive 2016 837
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 10,589
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2016 1,163
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2016 9,426
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2016 10,589
HTC_TST_DSD Sum of Test Result disaggregates 2016 10,589
LAB_CAP_DSD Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 13
TB_ART_DSD Female 2016 171
TB_ART_DSD Known HIV-positive 2016 64
TB_ART_DSD Male 2016 209
TB_ART_DSD Sum of Sex disaggregates 2016 380
TB_ART_DSD Sum of Test Status disaggregates 2016 64
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 453
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 380
TB_SCREEN_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 25,737
TB_SCREEN_DSD Sex: Female 2016 5,676
TB_SCREEN_DSD Sex: Male 2016 4,778
TB_SCREEN_DSD Sum of Sex disaggregates 2016 10,454
TB_SCREEN_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 10,454
TX_CURR_DSD Age/Sex: <1 Female 2016 226
TX_CURR_DSD Age/Sex: <1 Male 2016 225
TX_CURR_DSD Age/Sex: 1-4 Female 2016 97
TX_CURR_DSD Age/Sex: 1-4 Male 2016 95
TX_CURR_DSD Age/Sex: 5-14 Female 2016 446
TX_CURR_DSD Age/Sex: 5-14 Male 2016 438
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2016 17,365
TX_CURR_DSD Sum of age/sex disaggregates 2016 17,365
TX_NEW_DSD Breastfeeding status 2016 9
TX_NEW_DSD By Age/Sex: <1 Female 2016 55
TX_NEW_DSD By Age/Sex: <1 Male 2016 46
TX_NEW_DSD By Age/Sex: 1-4 Female 2016 85
TX_NEW_DSD By Age/Sex: 1-4 Male 2016 127
TX_NEW_DSD By Age/Sex: 10-14 Female 2016 124
TX_NEW_DSD By Age/Sex: 10-14 Male 2016 115
TX_NEW_DSD By Age/Sex: 15-19 Female 2016 125
TX_NEW_DSD By Age/Sex: 15-19 Male 2016 116
TX_NEW_DSD By Age/Sex: 20-24 Female 2016 302
TX_NEW_DSD By Age/Sex: 20-24 Male 2016 138
TX_NEW_DSD By Age/Sex: 25-49 Female 2016 1,232
TX_NEW_DSD By Age/Sex: 25-49 Male 2016 757
TX_NEW_DSD By Age/Sex: 5-9 Female 2016 93
TX_NEW_DSD By Age/Sex: 5-9 Male 2016 105
TX_NEW_DSD By Age/Sex: 50+ Female 2016 135
TX_NEW_DSD By Age/Sex: 50+ Male 2016 135
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 3,690
TX_NEW_DSD Pregnancy status 2016 27
TX_NEW_DSD Sum of Age/Sex disaggregates 2016 3,690
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 2,871
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 2,871